Within luminal A, luminal B, and ERBB2/HER2-enriched BC, PIK3CA mutations occurred among 2 of 21 cases (10%), 9 of 25 cases (36%), and 19 of 102 cases (19%), respectively (eFigure 3 in Supplement 1). This evidence concerns the gene ERBB2 and breast cancer.